Coming from a fairly large firm – Cubist Pharmaceuticals Inc. – before its $8.4bn acquisition by Merck & Co. Inc. in 2014, Morphic Therapeutic Inc. President and CEO Praveen Tipirneni said he ex
Interventional cardiology is a medical specialty well known for embracing promising new device technologies, and as a result, the field has progressed over the years well beyond its initial focus on c
IN VITRO DIAGNOSTICS Advanced Cell Diagnostics Inc. Advanced Cell Diagnostics raises $12mm through Series B round Advanced Cell Diagnostics Inc. (ACD; molecular pathology) has raised $12mm fro